The latest price target for Select Medical Hldgs (NYSE:SEM) was reported by UBS on January 3, 2025. The analyst firm set a price target for $21.00 expecting SEM to rise to within 12 months (a possible 3.09% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Select Medical Hldgs (NYSE:SEM) was provided by UBS, and Select Medical Hldgs maintained their neutral rating.

There is no last upgrade for Select Medical Hldgs

The last downgrade for Select Medical Holdings Corp happened on November 25, 2024 when Benchmark changed their price target from N/A to N/A for Select Medical Holdings Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Select Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Select Medical Hldgs was filed on January 3, 2025 so you should expect the next rating to be made available sometime around January 3, 2026.

While ratings are subjective and will change, the latest Select Medical Hldgs (SEM) rating was a maintained with a price target of $40.00 to $21.00. The current price Select Medical Hldgs (SEM) is trading at is $20.37, which is out of the analyst’s predicted range.